Concepedia

Shiho Kanai

SK

Statistics

Publications

4

Citations

118

H-Index

4

Active since

2011

Affiliations

Kyoto Pharmaceutical University(Current)

Shiho Kanai is an author at Kyoto Pharmaceutical University specializing in pharmacology, inflammation, and phospholipase a2 pathway.

Publications per year

2011–2016

4

Publications

4

ASB14780, an Orally Active Inhibitor of Group IVA Phospholipase A2, Is a Pharmacotherapeutic Candidate for Nonalcoholic Fatty Liver Disease

Shiho Kanai, Keiichi Ishihara, Eri Kawashita et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 38 citations

, , +17

Group IVA phospholipase A <sub>2</sub> participates in the progression of hepatic fibrosis

Keiichi Ishihara, Akira Miyazaki, Takeshi Nabe et al. · The FASEB Journal · 2012 · 37 citations

, , +16

Xanthoangelols isolated from <i>Angelica keiskei</i> inhibit inflammatory‐induced plasminogen activator inhibitor 1 (PAI‐1) production

Naoki Ohkura, Yoshitaka Nakakuki, Masahiko Taniguchi et al. · BioFactors · 2011 · 29 citations

, , +15

Group IVA phospholipase A2 deficiency prevents CCl4-induced hepatic cell death through the enhancement of autophagy

Keiichi Ishihara, Shiho Kanai, Kikuko Tanaka et al. · Biochemical and Biophysical Research Communications · 2016 · 14 citations

, , +14

1–4 of 4